Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis

BACKGROUND: Head-to-head comparator trials between first-line oral migraine preventatives and the new monoclonal antibodies (mAbs) blocking the calcitonin gene-related peptide (CGRP) pathway have not been published to date. OBJECTIVES: This study aimed to indirectly compare the clinical efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Overeem, Lucas Hendrik, Raffaelli, Bianca, Mecklenburg, Jasper, Kelderman, Tim, Neeb, Lars, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354912/
https://www.ncbi.nlm.nih.gov/pubmed/34272688
http://dx.doi.org/10.1007/s40263-021-00834-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354912/
https://www.ncbi.nlm.nih.gov/pubmed/34272688
http://dx.doi.org/10.1007/s40263-021-00834-9

Ejemplares similares